Skip to main content
. 2020 Feb 25;71(12):3144–3151. doi: 10.1093/cid/ciz1229

Figure 3.

Figure 3.

Changes in tenofovir disoproxil fumarate/emtricitabine PrEP coverage and HIV diagnosis rates, in the District of Columbia and 5 state quintiles, United States (US), 2012–2016. Abbreviations: DC, District of Columbia; EAPC, estimated annual percentage change; HIV, human immunodeficiency virus; PrEP, pre-exposure prophylaxis.